Heart Disease | Xconomy

by in

Entry	Blogger	Date	Location
Sequel Pharmaceuticals’ CEO on How to Start a Biotech and Sell it For a Bundle, and Repeat	Luke Timmerman	10/28/09	San Diego
Accumetrics Gunning To Be the Medical Diagnostics Standard for Managing Cardiovascular Disease	Bruce V. Bigelow	06/19/09	San Diego
Molecular Insight Names Peters CEO	Ryan McBride	05/13/09	Boston
Acusphere Cuts 40 Jobs	Ryan McBride	03/04/09	Boston
Isis Inches Closer Toward Profitability	Luke Timmerman	02/25/09	San Diego
HeartWare Takes $282M Buyout	Ryan McBride	02/13/09	Boston
Imaging Agent for Early Detection of Heart Disease, From Molecular Insight, Reaches Goal	Luke Timmerman	12/23/08	Boston
Epix Wins FDA Approval of Vasovist	Luke Timmerman	12/22/08	Boston
FDA Panel Votes Down Acusphere Drug	Ryan McBride	12/10/08	Boston
Acusphere Stock Temporarily Halted During FDA Panel on Heart Imaging Drug	Ryan McBride	12/10/08	Boston
Isis Pharmaceuticals’ Second Drug Aims to Block Marker of Heart Disease, Inflammation	Luke Timmerman	10/16/08	San Diego
Provasculon, a Biogen-backed Startup, Testing Regenerative Medicine on Hearts	Luke Timmerman	10/09/08	Boston
Cortria Hires CEO Grau To Develop Heart Drugs That Won’t Make You Red in the Face	Luke Timmerman	07/16/08	Boston
Rocky Mountain High: Atlas Venture Is Banking on microRNA for Miragen	Gregory T. Huang	05/22/08	Boston
Page 1 of 1

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.